Spire Wealth Management lessened its holdings in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 23.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange ...
Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...
Watkins brings more than 27 years of experience to Fieldfisher, with a focus on cross-border mergers and acquisitions, PE ...
The stock's rise snapped a three-day losing streak.
With growth in percutaneous fixes for the valve, surgeons at STS 2025 called for innovation, team-based care, and more data.
Learn more about whether Edwards Lifesciences Corporation or Stryker Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Matthew Edwards joined Brown Rudnick as a transactions partner in its global life sciences practice group in London, the firm ...
U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of ...
Orange County Grantmakers an association that advances equity among philanthropists and nonprofits has announced its 2025 Board of Directors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results